Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $105.26M | $89.88M | 12.26% | -$15.38M |
| Cogent Biosciences, Inc.COMM(COGT) | 6,964,375 | 6,964,375 | 0 | $54.32M | $41.72M | 5.69% | -$12.61M |
| Centessa Pharmaceuticals PlcADRS | 2,890,816 | 2,890,816 | 0 | $48.42M | $41.57M | 5.67% | -$6.85M |
| Mineralys Therapeutics, Inc.COMM(MLYS) | 2,470,265 | 2,470,265 | 0 | $30.41M | $39.23M | 5.35% | +$8.82M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 5,319,148 | 5,319,148 | 0 | $45.43M | $38.99M | 5.32% | -$6.44M |
| ABIVAX Société AnonymeADRS(ABVX) | 6,056,596 | 6,056,596 | 0 | $44.33M | $37.85M | 5.16% | -$6.48M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $37.95M | $34.24M | 4.67% | -$3.71M |
| Dyne Therapeutics, Inc.COMM(DYN) | 2,650,150 | 2,650,150 | 0 | $62.44M | $27.72M | 3.78% | -$34.72M |
| Dianthus Therapeutics, Inc.COMM(DNTH) | 1,501,624 | 1,501,624 | 0 | $32.74M | $27.24M | 3.72% | -$5.50M |
| Tyra Biosciences, Inc.COMM(TYRA) | 1,989,103 | 2,898,103 | +909,000 | $27.65M | $26.95M | 3.68% | -$696.2K |
| Xencor, Inc.COMM(XNCR) | 2,452,138 | 2,452,138 | 0 | $56.35M | $26.09M | 3.56% | -$30.26M |
| Disc Medicine, Inc.COMM(IRON) | 486,957 | 465,257 | -21,700 | $30.87M | $23.10M | 3.15% | -$7.78M |
| Tourmaline Bio IncCOMM | 1,477,593 | 1,477,593 | 0 | $29.97M | $22.47M | 3.07% | -$7.49M |
| Cidara Therapeutics IncCOMM | 1,005,901 | 1,005,901 | 0 | $26.09M | $21.67M | 2.96% | -$4.43M |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 4,643,812 | 5,943,812 | +1,300,000 | $17.55M | $21.04M | 2.87% | +$3.49M |
| Soleno Therapeutics IncCOMM | 550,000 | 275,000 | -275,000 | $24.72M | $19.65M | 2.68% | -$5.07M |
| EyePoint, Inc.COMM(EYPT) | 3,572,335 | 3,572,335 | 0 | $26.61M | $19.36M | 2.64% | -$7.25M |
| Structure Therapeutics IncADRS | 1,063,000 | 1,063,000 | 0 | $28.83M | $18.40M | 2.51% | -$10.43M |
| Upstream Bio, Inc.COMM(UPB) | 2,801,763 | 2,801,763 | 0 | $44.86M | $17.15M | 2.34% | -$27.71M |
| RAPT Therapeutics, Inc.COMM | 13,135,260 | 13,090,200 | -45,060 | $19.75M | $15.97M | 2.18% | -$3.78M |
| Fulcrum Therapeutics, Inc.COMM(FULC) | 5,250,000 | 5,250,000 | 0 | $24.68M | $15.12M | 2.06% | -$9.55M |
| Astria Therapeutics IncCOMM | 2,761,861 | 2,761,861 | 0 | $24.69M | $14.75M | 2.01% | -$9.94M |
| Tango Therapeutics, Inc.COMM(TNGX) | 10,736,000 | 10,736,000 | 0 | $33.17M | $14.71M | 2.01% | -$18.47M |
| COMPASS Pathways plcADRS(CMPS) | 3,858,000 | 3,858,000 | 0 | $14.58M | $11.03M | 1.51% | -$3.55M |
| Kura Oncology, Inc.COMM(KURA) | 1,423,642 | 1,423,642 | 0 | $12.40M | $9.40M | 1.28% | -$3.00M |
| Third Harmonic Bio IncCOMM | 2,505,424 | 2,505,424 | 0 | $25.78M | $8.69M | 1.19% | -$17.09M |
| Silence Therapeutics plcADRS(SLN) | 3,033,560 | 3,033,560 | 0 | $20.87M | $8.55M | 1.17% | -$12.32M |
| Adverum Biotechnologies IncCOMM | 1,796,482 | 1,796,482 | 0 | $8.39M | $7.85M | 1.07% | -$538.9K |
| Vistagen Therapeutics, Inc.COMM(VTGN) | 2,676,580 | 2,676,580 | 0 | $7.90M | $6.69M | 0.91% | -$1.20M |
| Aerovate Therapeutics IncCOMM | 2,240,809 | 2,240,809 | 0 | $5.94M | $5.62M | 0.77% | -$313.7K |
| Entrada Therapeutics, Inc.COMM(TRDA) | 584,955 | 584,955 | 0 | $10.11M | $5.29M | 0.72% | -$4.83M |
| MBX Biosciences, Inc.COMM(MBX) | 650,000 | 650,000 | 0 | $11.98M | $4.80M | 0.65% | -$7.18M |
| Avalo Therapeutics, Inc.COMM(AVTX) | 483,000 | 483,000 | 0 | $3.59M | $3.87M | 0.53% | +$280.1K |
| Kodiak Sciences Inc.COMM(KOD) | 1,145,538 | 1,145,538 | 0 | $11.40M | $3.21M | 0.44% | -$8.18M |
| Nektar TherapeuticsCOMM(NKTR) | 4,000,000 | 4,000,000 | 0 | $3.72M | $2.72M | 0.37% | -$1.00M |
| Ventyx Biosciences IncCOMM | 316,195 | 316,195 | 0 | $692.5K | $363.6K | 0.05% | -$328.8K |
| Cabaletta Bio, Inc.COMM(CABA) | 86,795 | 86,795 | 0 | $197.0K | $120.2K | 0.02% | -$76.8K |
| Keros Therapeutics, Inc.COMM(KROS) | 550,000 | 0 | -550,000 | $8.71M | $0 | — | -$8.71M |